Evommune ($EVMN) Insider Trading & Smart Money Activity

Evommune, Inc. · Biotechnology · Latest filing Jun 30, 2026

Evommune, Inc. ($EVMN) has 4 13F position changes and 1 analyst rating on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 4
Analyst ratings on file: 1

EVMN insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	4 / 0
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All EVMN insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	1W	1M	Story
Jun 30, 2026	Analyst	Morgan Stanley	Reiterates to buy		PT $26	+0.4%	-14.6%	Read
May 15, 2026	13F	Rtw Investments	Added	+218.56K sh	$19.96M	-0.2%	-9.1%	Read
May 15, 2026	13F	Rtw Investments	Added	+218.56K sh	$29.79M	-0.2%	-9.1%	Read
May 15, 2026	13F	Baker Bros. Advisors	New	+847.39K sh	$11.26M	-0.2%	-9.1%	Read
May 15, 2026	13F	Baker Bros. Advisors	New	+847.39K sh	$16.80M	-0.2%	-9.1%	—

1W / 1M / 6M = how EVMN moved from the trade or filing date.

Institutions moving EVMN (13F)

Analyst ratings on EVMN

Date	Firm	Action	Rating	Price target	1W	1M	6M	Story
Jun 30, 2026	Morgan Stanley	Reiterates	buy	$26	+0.4%	-14.6%		Read

Frequently asked questions

Which institutions changed their EVMN positions?

Recent 13F filers moving the stock include Rtw Investments and Baker Bros. Advisors.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text